Evidence map›Paper›PMID 36418642›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2023

Current professional standing of young medical oncologists in Spain: a nationwide survey by the Spanish Society of Medical Oncology + MIR section.

Domingo Antonio Sanchez Martinez, Aliica Quilez-Cutillas, Pablo Jimenez-Labaig, Andrea Sesma, Noelia Tarazona, Vilma Pacheco-Barcia, Berta Obispo, David Paez, Teresa Quintanar, Manuel Sanchez-Canovas and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 2 countries.

Domingo Antonio Sanchez MartinezDepartment of Medical Oncology, IMIB, Virgen de La Arrixaca University Hospital, Murcia, Región de Murcia, Spain.ORCID http://orcid.org/0000-0003-2073-0679
Aliica Quilez-CutillasDepartment of Medical Oncology, Can Misses Hospital, Área de Salud de Ibiza y Formentera (ASEF), Ibiza, Illes Balears, Spain.
Pablo Jimenez-LabaigDepartment of Medical Oncology, Cruces University Hospital, Barakaldo, Bizkaia, Spain.
Andrea SesmaDepartment of Medical Oncology, Lozano Blesa University Clinical Hospital, Zaragossa, Aragón, Spain.
Noelia TarazonaDepartment of Medical Oncology, INCLIVA Biomedical Research Institute, Comunitat Valenciana, Spain.
Vilma Pacheco-BarciaDepartment of Medical Oncology, Torrejón University Hospital, Madrid, Spain.
Berta ObispoDepartment of Medical Oncology, Infanta Leonor University Hospital, Madrid, Spain.
David PaezDepartment of Medical Oncology, Santa Creu i Sant Pau University Hospital, Barcelona, Catalunya, Spain.
Teresa QuintanarDepartment of Medical Oncology, Elche University General Hospital, Elche, Comunitat Valenciana, Spain.
Manuel Sanchez-CanovasDepartment of Hematology and Medical Oncology, Morales Meseguer University General Hospital, Murcia, Región de Murcia, Spain.
Ana Fernandez MontesDepartment of Medical Oncology, University Hospital Complex of Ourense (CHUO), Ourense, Galicia, Spain.
Enriqueta FelipVall d'Hebron Institute of Oncology (VHIO), Medical Oncology Department, Vall d'Hebron University Hospital, Univesitat Autònoma de Barcelona (UAB), 119-129, 08035, Barcelona, Catalunya, Spain.
Alvaro Rodriguez-LescureDepartment of Medical Oncology, Elche University General Hospital, Elche, Comunitat Valenciana, Spain.
Elena ElezVall d'Hebron Institute of Oncology (VHIO), Medical Oncology Department, Vall d'Hebron University Hospital, Univesitat Autònoma de Barcelona (UAB), 119-129, 08035, Barcelona, Catalunya, Spain. meelez@vhio.net.
Hospital General Universitario de Elche · ESComplejo Hospitalario de Ourense · ESHebron University · PSHospital Can Misses · ESHospital Clínico Universitario Lozano Blesa · ESHospital de Cruces · ESHospital de Sant Pau · ESHospital General Universitario Morales Meseguer · ESHospital Universitario de Torrejón · ESHospital Universitario Infanta Leonor · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is a lack of knowledge about the career paths and employment situation of young medical oncologists. The aim of our study was to evaluate the current professional standing of these professionals in Spain.

methodsThe Spanish Society of Medical Oncology + MIR section conducted a national online survey in May 2021 of young medical oncology consultants (< 6 years of expertise) and final year medical oncology residents.

resultsA total of 162 responses were eligible for analysis and included participants from 16 autonomous communities; 64% were women, 80% were consultants, and 20% were residents. More than half of the participants performed routine healthcare activity and only 7% research activity. Almost three quarters (73%) were subspecialized in a main area of interest and almost half of these chose this area because it was the only option available after residency. Half of the respondents (51%) considered working abroad and 81% believed the professional standing in Spain was worse than in other countries. After finishing their residency, only 22 were offered a job at their training hospital. Just 16% of participants had a permanent employment contract and 87% were concerned (score of ≥ 5 on a scale of 1-10) about their job stability. In addition, one quarter of the participants in our study showed an interest in increasing their research activity.

conclusionsThe choice of subspecialty in medical oncology may depend on job opportunities after residency rather than personal interest. The abundance of temporary contracts may have influenced the job stability concerns observed. Future mentoring strategies should engage in building a long-term career path for young medical oncologists.

Indexed as

Medical OncologyOncologistsEmploymentFemaleHumansMaleSpainSurveys and QuestionnairesCareer pathJob performanceOncology professionalsProfessional standingYoung oncologist

Identifiers

PMID36418642
PMCPMC9685015
OpenAlexW4309928002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.